At a glance
- Originator AstraZeneca
- Class Analgesics; Antidementias; Neuroprotectants; Small molecules
- Mechanism of Action Imidazoline receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 04 Mar 2003 No development reported - Preclinical for Pain in USA (unspecified route)
- 29 Nov 2000 Preclinical development for Pain in USA (Unknown route)